. Lecanemab: European drug agency rejects Alzheimer's drug amid debate over efficacy and safety. BMJ. 2024 Jul 29;386:q1692. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.